be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Show search box

2015-08-12

Mutations in a cell line stops stem-cell trial to cure blindness

Mutations in a cell line stops stem-cell trial to cure blindness

Induced pluripotent stem cells (iPSC) turned into specialized retinal cells were meant to cure the damage caused by age-related macular degeneration leading to blindness. The trial was halted due to mutations identified in cells of a second patient.... Read more

Tags clinical trials , stem cells , mutations , macular degeneration , blindness , iPSC